Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Renalytix's KidneyIntelX is a "Star" due to its high market growth and strong market share
This high rate suggests a stable
vital for gene therapy advancements
Compliance costs for energy suppliers rose approximately 10% in 2024 due to stricter environmental regulations
This external risk necessitates proactive strategies to mitigate adverse effects
EXTREME REACH SWOT ANALYSIS TEMPLATE RESEARCH B_137 Renalytix's KidneyIntelX is a "Star"Go Beyond the Preview Access the Full Strategic Report Discover how Extreme Reach's unique ad tech stack, client relationships, and data capabilities translate into competitive advantage and where regulatory shifts, market consolidation, or tech disruption could erode value. Purchase the full SWOT analysis to get a research backed, editable report and Excel matrix with strategic recommendations, financial context, and ready to use slides for investors
US$ 187.50
US$ 3800.00
US$ 48.99
US$ 12995.00
US$ 2249.50
US$ 15191.50
US$ 12450.00
US$ 2249.50
US$ 21.75
US$ 249.50
US$ 1949.50
